Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02423954
Title Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Western Regional Medical Center
Indications

Advanced Solid Tumor

Therapies

Temsirolimus

Nivolumab

Capecitabine

Irinotecan

Age Groups: adult
Covered Countries USA


No variant requirements are available.